## Abstract Carbon‐13 and carbon‐14 labeled forms of the title compound have been prepared from the correspondingly labeled forms of 8‐chloro‐1‐methyl‐6‐phenyl‐4H‐__s__‐triazolo[4,3‐a][1,4]benzodiazepine (__3__)Alprazolam is the generic USAN name for this compound. . A modified and more convenient
The synthesis of [14C]-3S,4R-4-(4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine hydrochloride (BRL 29060A), and mechanistic studies using carbon-13 labelling
✍ Scribed by K. Willcocks; R. D. Barnes; D. C. Rustidge; D. J. D. Tidy
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- French
- Weight
- 555 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Paroxetine, BRL 29060A 1 has been labelled with both carbon‐14 and carbon‐13. Hydroxymethylation of 4‐(4‐fluorophenyl)‐1‐methyl‐1,2,5,6‐tetrahydropyridine, using [^14^C]formaldehyde, produced an enantiomeric mixture of products which was taken without separation through a multistage sequence. Resolution of the mixture of stereoisomers at the penultimate step gave [^14^C]BRL 29060A with the required configuration. The overall radiochemical yield was 8%. At some stage in this process, as shown by C‐13 labelling studies, scrambling of the label took place to give BRL 29060A with the majority of the label in the C‐2 position of the piperidine ring and the remainder at the expected 7‐methylene position. Further investigations of this route using carbon‐13 as the label are described. When sesamol, (3,4‐methylenedioxyphenol) was reacted with the O‐benzene sulphonate of (±)‐cis‐4‐(4‐fluorophenyl)‐3‐(hydroxy[^13^C]methyl)‐l‐methylpiperidine, an inversion of configuration resulted via the previously described 1‐aza[3.1.1]bicycloheptane ring system. It is also shown that the corresponding (±)‐trans‐substituted piperidine, under similar conditions, does not undergo this inversion.
📜 SIMILAR VOLUMES
## Abstract A group of radioactive 1,4‐benzodiazepine derivatives have been synthesized from glycine‐1‐^14^C. The subject compounds are labeled with carbon‐14 in the 2‐position of the 1,4‐benzodiazepine ring system.
## Abstract 5′‐[^14^C~1~]Panadiplon was prepared in 3 steps starting from [^14^C~1~]cyclopropane carboxylic acid and 3‐(5′‐cyano‐1,2,4‐oxadiazol‐3‐yl)‐5‐(1‐methylethyl)‐imidazo‐[1,5a]‐quinoxalin‐4(5H)‐one. 3a, 4‐[^13^C~2~]Panadiplon was prepared in two steps from ^13^C~2~‐oxalic acid and N‐1‐(1‐met
The partial ergoline LY228729 (1) which was a potent 5HT 1A agonist has been studied clinically. Somewhat later, a related analog, (S)-di-n-propyl-(8-isoxazol-5-yl-1,2,3,4-tetrahydronaphthalen-2-yl)amine (2a) which in addition to potent 5HT 1A agonist activity was a muscarinic antagonist, was chosen
## Abstract Procedures were developed for synthesis of the carcinogenic compounds 5‐methylchrysene‐5‐^14^C, 2‐methylaniline‐methyl‐^14^C and 3‐methyl‐2‐naphthyl‐amine‐methyl‐^14^C. In each case, label was introduced with ^14^CO~2~ and yields were acceptable for preparation of these compounds for me